teloxantrone has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elslager, EF; Hoftiezer, JM; Jackson, RC; Johnson, JL; Leopold, WR; Shillis, JL; Showalter, HD; Turner, WR; Werbel, LM | 1 |
| Besserer, JA; Boritzki, TJ; Fry, DW; Jackson, RC | 1 |
2 other study(ies) available for teloxantrone and Leukemia L 1210
| Article | Year |
|---|---|
Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Topics: Animals; Anthracenes; Antineoplastic Agents; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Magnetic Resonance Spectroscopy; Mice; Mitoxantrone; Pyrazoles; Spectrophotometry; Structure-Activity Relationship | 1987 |
In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles).
Topics: Aminoacridines; Amsacrine; Animals; Anthraquinones; Colony-Forming Units Assay; DNA; Doxorubicin; Kinetics; Leukemia L1210; Mice; Mitoxantrone; Nucleic Acids; Nucleotides; Oxygen Consumption; Pyrazoles; RNA | 1985 |